MedPath

Rotavirus vaccine

Generic Name
Rotavirus vaccine
Brand Names
Rotarix, Rotateq
Drug Type
Biotech
Chemical Formula
-
CAS Number
-
Unique Ingredient Identifier
-
Background

Rotavirus commonly infects children and infants causing severe diarrhea and vomiting leading to potentially fatal dehydration. Two rotavirus vaccines are available for the prevention of rotavirus gastroenteritis, Rotateq and Rotarix. Rotateq is a live vaccine consisting of 5 reassorted human-bovine viral strains. Rotarix is a live attenuated vaccine containing the 89-12 human strain. Rotavirus vaccines are 90% effective in protecting against severe rotavirus infection.

Indication

Rotarix is indicated for prevention of rotavirus gastroenteritis caused by G1, G3, G4, and G9 types in infants aged 6-24 weeks .

Rotateq is indicated for the prevention of rotavirus gastroenteritis caused by G1, G2, G3, G4, and G9 types in infants aged 6-32 weeks .

Associated Conditions
Rotavirus Gastroenteritis caused by rotavirus G1, Rotavirus Gastroenteritis caused by rotavirus G2, Rotavirus Gastroenteritis caused by rotavirus G3, Rotavirus Gastroenteritis caused by rotavirus G4, Rotavirus Gastroenteritis caused by rotavirus G9
Associated Therapies
-
© Copyright 2025. All Rights Reserved by MedPath